Annie Jackson
Neurology · Rutherfordton, NCNPI 1891839866
Payments from drug & device makers
Across 148 payments — averaging $19.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- MDD US Operations, LLC$703
- Sunovion Pharmaceuticals Inc.$220
- Teva Pharmaceuticals USA, Inc.$194
- Supernus Pharmaceuticals, Inc.$166
- AbbVie$160
- Lilly USA, LLC$158
- plus $1K from 27 others
What the payments were for
- Food & beverage$2,75597%
- Education$723%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| MDD US Operations, LLC | 22 | $703 |
| Sunovion Pharmaceuticals Inc. | 8 | $220 |
| Teva Pharmaceuticals USA, Inc. | 13 | $194 |
| Supernus Pharmaceuticals, Inc. | 6 | $166 |
| AbbVie | 10 | $160 |
| Lilly USA, LLC | 10 | $158 |
| Sanofi | 7 | $124 |
| Amneal Pharmaceuticals LLC | 7 | $119 |
| Upsher-smith Laboratories LLC | 6 | $103 |
| UCB, Inc. | 8 | $100 |
| Aquestive Therapeutics, Inc. | 6 | $97 |
| Avanir Pharmaceuticals, Inc. | 5 | $80 |
| Eisai Inc. | 4 | $79 |
| E.r. Squibb & Sons, L.L.C. | 4 | $60 |
| Adamas Pharmaceuticals, Inc. | 4 | $55 |
| Novartis | 4 | $50 |
| Amgen | 3 | $47 |
| Greenwich Biosciences, Inc. | 3 | $36 |
| Biohaven Pharmaceuticals, Inc. | 2 | $32 |
| CSL Behring | 1 | $26 |
| Genentech USA, Inc. | 2 | $25 |
| Pfizer | 2 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| GE HealthCare | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| Boston Scientific | 1 | $17 |
| SK Life Science, Inc. | 1 | $16 |
| Biogen | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Impel Pharmaceuticals Inc. | 1 | $12 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
| Grifols USA, LLC | 1 | $12 |
| Zyla Life Sciences, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MYOBLOC$192
How this compares
$2,827 in reported general payments places this provider in the 60th percentile of 566 neurology providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbidopa-LevodopaCarbidopa/Levodopa | 44 | $385 |
| ClopidogrelClopidogrel Bisulfate | 12 | $84 |
Paid to pharmacies, not to this prescriber.
Other neurology in Rutherfordton
- Mohammad BolouriCharlotte$16.6M
- Katherine PetersDurham$11M
- John ScagnelliRaleigh$9.3M
- T RaoCharlotte$4M
- Pramod SethiGreensboro$2.9M
- Robert ArmstrongAsheville$2.7M
- Casey JeffreysRaleigh$2.2M
- Mitchell IsaacWinston Salem$2.2M
- Vern JuelDurham$2M
- Marshall FreemanGreensboro$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.